Product Information
TRIAZOLAM 0.25 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3011 per EA under NDC 59762371809. Its NADAC has been published 492 times since Mar 22, 2017.
FDA first approved this application on Nov 15, 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762371809
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TRIAZOLAMApproval Type
Authorized Generic (NDA)
FDA Application
NDA017892FDA Approved
11/15/1982
TE Code
AB
On Market Since
11/15/1982
Pharmacological Classes
Price Statistics
The NADAC for TRIAZOLAM 0.25 MG TABLET has been published 492 times since Mar 22, 2017, and over the history we have for it it has declined 77.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3011 per EA |
|---|---|
| All-time high | $1.6632 (Mar 14, 2018) |
| All-time low | $0.2380 (Nov 20, 2024) |
| 52-week high | $0.3765 |
| 52-week low | $0.3011 |
| Median price | $1.1713 |
| Average price | $0.9998 |
| Largest weekly change | +51.7% (May 22, 2024) |
| Weeks tracked | 492 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAZOLAM 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIAZOLAM 0.25 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3011 per EA (NDC 59762371809), effective Aug 19, 2026.
How has the price of TRIAZOLAM 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIAZOLAM 0.25 MG TABLET has declined 77.7%. It has been tracked across 492 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for TRIAZOLAM 0.25 MG TABLET?
Since Mar 22, 2017, the NADAC for TRIAZOLAM 0.25 MG TABLET has ranged from a low of $0.2380 (Nov 20, 2024) to a high of $1.6632 (Mar 14, 2018), with a median of $1.1713 per EA.
Are there cheaper alternatives to TRIAZOLAM 0.25 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIAZOLAM 0.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIAZOLAM 0.25 MG TABLET?
TRIAZOLAM 0.25 MG TABLET (NDC 59762371809) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.